Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

• Ignacio Blanco,

  Affiliation Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Karoline Kuchenbaecker,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Daniel Cuadras,

  Affiliation Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Xianshu Wang,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America

  ⨯
• Daniel Barrowdale,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Gorka Ruiz de Garibay,

  Affiliation Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Pablo Librado,

  Affiliation Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain

  ⨯
• Alejandro Sánchez-Gracia,

  Affiliation Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain

  ⨯
• Julio Rozas,

  Affiliation Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain

  ⨯
• Núria Bonifaci,

  Affiliation Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Lesley McGuffog,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Vernon S. Pankratz,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Abul Islam,

  Affiliation Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh

  ⨯
• Francesca Mateo,

  Affiliation Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Antoni Berenguer,

  Affiliation Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Anna Petit,

  Affiliation Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Isabel Català,

  Affiliation Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Joan Brunet,

  Affiliation Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain

  ⨯
• Lidia Feliubadaló,

  Affiliation Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Eva Tornero,

  Affiliation Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Javier Benítez,

  Affiliation Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain

  ⨯
• Ana Osorio,

  Affiliation Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain

  ⨯
• Teresa Ramón y Cajal,

  Affiliation Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain

  ⨯
• Heli Nevanlinna,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Kristiina Aittomäki,

  Affiliation Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Banu K. Arun,

  Affiliation Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Amanda E. Toland,

  Affiliation Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Beth Y. Karlan,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Christine Walsh,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Jenny Lester,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Mark H. Greene,

  Affiliation Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America

  ⨯
• Phuong L. Mai,

  Affiliation Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America

  ⨯
• Robert L. Nussbaum,

  Affiliation Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Irene L. Andrulis,

  Affiliation Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Susan M. Domchek,

  Affiliation Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Katherine L. Nathanson,

  Affiliation Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Timothy R. Rebbeck,

  Affiliation Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Rosa B. Barkardottir,

  Affiliation Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland

  ⨯
• Anna Jakubowska,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Jan Lubinski,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Katarzyna Durda,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Katarzyna Jaworska-Bieniek,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Kathleen Claes,

  Affiliation Center for Medical Genetics, Ghent University, Ghent, Belgium

  ⨯
• Tom Van Maerken,

  Affiliation Center for Medical Genetics, Ghent University, Ghent, Belgium

  ⨯
• Orland Díez,

  Affiliation Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

  ⨯
• Thomas V. Hansen,

  Affiliation Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Lars Jønson,

  Affiliation Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Anne-Marie Gerdes,

  Affiliation Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Bent Ejlertsen,

  Affiliation Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Miguel de la Hoya,

  Affiliation Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain

  ⨯
• Trinidad Caldés,

  Affiliation Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain

  ⨯
• Alison M. Dunning,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Clare Oliver,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Elena Fineberg,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Margaret Cook,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Susan Peock,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Emma McCann,

  Affiliation All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom

  ⨯
• Alex Murray,

  Affiliation All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom

  ⨯
• Chris Jacobs,

  Affiliation Clinical Genetics, Guy’s and St. Thomas’ National Health Service (NHS) Foundation Trust, London, United Kingdom

  ⨯
• Gabriella Pichert,

  Affiliation Clinical Genetics, Guy’s and St. Thomas’ National Health Service (NHS) Foundation Trust, London, United Kingdom

  ⨯
• Fiona Lalloo,

  Affiliation Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom

  ⨯
• Carol Chu,

  Affiliation Yorkshire Regional Genetics Service, Leeds, United Kingdom

  ⨯
• Huw Dorkins,

  Affiliation North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom

  ⨯
• Joan Paterson,

  Affiliation Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom

  ⨯
• Kai-Ren Ong,

  Affiliation West Midlands Regional Genetics Service, Birmingham Women’s Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom

  ⨯
• Manuel R. Teixeira,

  Affiliation Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal

  ⨯
• Teixeira,

  Affiliation Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands

  ⨯
• Frans B. L. Hogervorst,

  Affiliation Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands

  ⨯
• Annemarie H. van der Hout,

  Affiliation Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands

  ⨯
• Caroline Seynaeve,

  Affiliation Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Rob B. van der Luijt,

  Affiliation Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands

  ⨯
• Marjolijn J. L. Ligtenberg,

  Affiliation Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands

  ⨯
• Peter Devilee,

  Affiliations Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands, Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Juul T. Wijnen,

  Affiliations Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands, Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Matti A. Rookus,

  Affiliation Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Hanne E. J. Meijers-Heijboer,

  Affiliation Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands

  ⨯
• Marinus J. Blok,

  Affiliation Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands

  ⨯
• Ans M. W. van den Ouweland,

  Affiliation Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Cora M. Aalfs,

  Affiliation Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Gustavo C. Rodriguez,

  Affiliation Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Kelly-Anne A. Phillips,

  Affiliation Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

  ⨯
• Marion Piedmonte,

  Affiliation Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Stacy R. Nerenstone,

  Affiliation Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America

  ⨯
• Victoria L. Bae-Jump,

  Affiliation Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• David M. O'Malley,

  Affiliation Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America

  ⨯
• Elena S. Ratner,

  Affiliation Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Rita K. Schmutzler,

  Affiliation Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany

  ⨯
• Barbara Wappenschmidt,

  Affiliation Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany

  ⨯
• Kerstin Rhiem,

  Affiliation Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany

  ⨯
• Christoph Engel,

  Affiliation Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany

  ⨯
• Alfons Meindl,

  Affiliation Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany

  ⨯
• Nina Ditsch,

  Affiliation Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany

  ⨯
• Norbert Arnold,

  Affiliation Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany

  ⨯
• Hansjoerg J. Plendl,

  Affiliation Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany

  ⨯
• Dieter Niederacher,

  Affiliation Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany

  ⨯
• Christian Sutter,

  Affiliation Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany

  ⨯
• Shan Wang-Gohrke,

  Affiliation Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany

  ⨯
• Doris Steinemann,

  Affiliation Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany

  ⨯
• Sabine Preisler-Adams,

  Affiliation Institute of Human Genetics, University of Münster, Münster, Germany

  ⨯
• Karin Kast,

  Affiliation Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

  ⨯
• Raymonda Varon-Mateeva,

  Affiliation Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany

  ⨯
• Andrea Gehrig,

  Affiliation Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany

  ⨯
• Anders Bojesen,

  Affiliation Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark

  ⨯
• Inge Sokilde Pedersen,

  Affiliation Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark

  ⨯
• Lone Sunde,

  Affiliation Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Uffe Birk Jensen,

  Affiliation Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Mads Thomassen,

  Affiliation Department of Clinical Genetics, Odense University Hospital, Odense, Denmark

  ⨯
• Torben A. Kruse,

  Affiliation Department of Clinical Genetics, Odense University Hospital, Odense, Denmark

  ⨯
• Lenka Foretova,

  Affiliation Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic

  ⨯
• Paolo Peterlongo,

  Affiliation Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy

  ⨯
• Loris Bernard,

  Affiliation Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy

  ⨯
• Bernard Peissel,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Giulietta Scuvera,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Siranoush Manoukian,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Paolo Radice,

  Affiliation Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Laura Ottini,

  Affiliation Department of Molecular Medicine, "Sapienza" University, Rome, Italy

  ⨯
• Marco Montagna,

  Affiliation Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy

  ⨯
• Simona Agata,

  Affiliation Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy

  ⨯
• Christine Maugard,

  Affiliation Laboratoire de Diagnostic Génétique et Service d'Onco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France

  ⨯
• Jacques Simard,

  Affiliation Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada

  ⨯
• Penny Soucy,

  Affiliation Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada

  ⨯
• Andreas Berger,

  Affiliation Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Anneliese Fink-Retter,

  Affiliation Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Christian F. Singer,

  Affiliation Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Christine Rappaport,

  Affiliation Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Daphne Geschwantler-Kaulich,

  Affiliation Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Muy-Kheng Tea,

  Affiliation Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Georg Pfeiler,

  Affiliation Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• BCFR,

  Affiliation Breast Cancer Family Registry (BCFR), Cancer Prevention Institute of California, Fremont, California, United States of America

  ⨯
• Esther M. John,

  Affiliation Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America

  ⨯
• Alex Miron,

  Affiliation Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Susan L. Neuhausen,

  Affiliation Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America

  ⨯
• Mary Beth Terry,

  Affiliation Department of Epidemiology, Columbia University, New York, New York, United States of America

  ⨯
• Wendy K. Chung,

  Affiliation Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Mary B. Daly,

  Affiliation Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• David E. Goldgar,

  Affiliation Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America

  ⨯
• Ramunas Janavicius,

  Affiliation Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania

  ⨯
• Cecilia M. Dorfling,

  Affiliation Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa

  ⨯
• Elisabeth J. van Rensburg,

  Affiliation Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa

  ⨯
• Florentia Fostira,

  Affiliation Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece

  ⨯
• Irene Konstantopoulou,

  Affiliation Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece

  ⨯
• Judy Garber,

  Affiliation Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Andrew K. Godwin,

  Affiliation Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Edith Olah,

  Affiliation Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary

  ⨯
• Steven A. Narod,

  Affiliation Women's College Research Institute, University of Toronto, Toronto, Canada

  ⨯
• Gad Rennert,

  Affiliation Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel

  ⨯
• Shani Shimon Paluch,

  Affiliation The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Yael Laitman,

  Affiliation The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel

  ⨯
• Eitan Friedman,

  Affiliations The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel

  ⨯
• SWE-BRCA,

  Affiliation Swedish BRCA1 and BRCA2 Study (SWE-BRCA), Stockholm, Sweden

  ⨯
• Annelie Liljegren,

  Affiliation Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Johanna Rantala,

  Affiliation Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Marie Stenmark-Askmalm,

  Affiliation Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

  ⨯
• Niklas Loman,

  Affiliation Department of Oncology, Lund University Hospital, Lund, Sweden

  ⨯
• Evgeny N. Imyanitov,

  Affiliation N.N. Petrov Institute of Oncology, St.-Petersburg, Russia

  ⨯
• Ute Hamann,

  Affiliation Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• kConFab Investigators,

  Affiliation Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Peter MacCallum Cancer Center, Melbourne, Australia

  ⨯
• Amanda B. Spurdle,

  Affiliation Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Sue Healey,

  Affiliation Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Jeffrey N. Weitzel,

  Affiliation Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America

  ⨯
• Josef Herzog,

  Affiliation Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America

  ⨯
• David Margileth,

  Affiliation St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America

  ⨯
• Chiara Gorrini,

  Affiliation The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada

  ⨯
• Manel Esteller,

  Affiliations Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L’Hospitalet del Llobregat, Catalonia, Spain, Department of Physiological Sciences II, School of Medicine, University of Barcelona, L’Hospitalet del Llobregat, Catalonia, Spain, Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain

  ⨯
• Antonio Gómez,

  Affiliation Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Sergi Sayols,

  Affiliation Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Enrique Vidal,

  Affiliation Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Holger Heyn,

  Affiliation Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• GEMO,

  Affiliation Groupe Genetique et Cancer (GEMO), National Cancer Genetics Network, French Federation of Comprehensive Cancer Centers (UNICANCER), Paris, France

  ⨯
• Dominique Stoppa-Lyonnet,

  Affiliations Department of Tumour Biology, Institut Curie, Paris, France, Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Melanie Léoné,

  Affiliation Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon–Centre Léon Bérard, Lyon, France

  ⨯
• Laure Barjhoux,

  Affiliation Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France

  ⨯
• Marion Fassy-Colcombet,

  Affiliation Department of Tumour Biology, Institut Curie, Paris, France

  ⨯
• Antoine de Pauw,

  Affiliation Department of Tumour Biology, Institut Curie, Paris, France

  ⨯
• Christine Lasset,

  Affiliation Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et d’Epidémiologie Génétique, Centre Léon Bérard, Lyon, France

  ⨯
• Sandra Fert Ferrer,

  Affiliation Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France

  ⨯
• Laurent Castera,

  Affiliation Department of Tumour Biology, Institut Curie, Paris, France

  ⨯
• Pascaline Berthet,

  Affiliation Centre François Baclesse, Caen, France

  ⨯
• François Cornelis,

  Affiliation Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France

  ⨯
• Yves-Jean Bignon,

  Affiliation Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France

  ⨯
• Francesca Damiola,

  Affiliation Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France

  ⨯
• Sylvie Mazoyer,

  Affiliation Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France

  ⨯
• Olga M. Sinilnikova †,

  † Deceased.

  Affiliations Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon–Centre Léon Bérard, Lyon, France, Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France

  ⨯
• Christopher A. Maxwell,

  Affiliation Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada

  ⨯
• Joseph Vijai,

  Affiliation Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Mark Robson,

  Affiliation Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Noah Kauff,

  Affiliation Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Marina J. Corines,

  Affiliation Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Danylko Villano,

  Affiliation Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Julie Cunningham,

  Affiliations Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Adam Lee,

  Affiliation Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Noralane Lindor,

  Affiliation Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America

  ⨯
• Conxi Lázaro,

  Affiliation Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• Douglas F. Easton,

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Kenneth Offit,

  Affiliation Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Georgia Chenevix-Trench,

  Affiliation Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Fergus J. Couch,

  Affiliations Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Antonis C. Antoniou ,

  * E-mail: aca20@medschl.cam.ac.uk (ACA); mapujana@iconcologia.net (MAP)

  Affiliation Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
•  [ ... ],
• Miguel Angel Pujana

  * E-mail: aca20@medschl.cam.ac.uk (ACA); mapujana@iconcologia.net (MAP)

  Affiliation Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain

  ⨯
• [ view all ]
• [ view less ]